NasdaqCM - Nasdaq Real Time Price USD
Fortress Biotech, Inc. (FBIO)
1.7200
-0.0600
(-3.37%)
As of 10:20:12 AM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.43 | -0.5 | -1.64 | -0.94 |
| Low Estimate | -0.43 | -0.5 | -1.64 | -0.94 |
| High Estimate | -0.43 | -0.5 | -1.64 | -0.94 |
| Year Ago EPS | -- | -0.76 | -2.87 | -1.64 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 15.78M | 20.01M | 73.02M | 153.83M |
| Low Estimate | 14.44M | 19.88M | 72.34M | 150.56M |
| High Estimate | 17.12M | 20.15M | 73.7M | 157.1M |
| Year Ago Sales | 14.9M | 14.63M | 57.67M | 73.02M |
| Sales Growth (year/est) | 5.94% | 36.80% | 26.60% | 110.67% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -1.22 | -0.27 | -0.75 | -0.44 |
| EPS Actual | -0.73 | -0.76 | -0.3 | -0.48 |
| Difference | 0.49 | -0.49 | 0.45 | -0.04 |
| Surprise % | 40.33% | -181.48% | 60.09% | -9.09% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.43 | -0.5 | -1.64 | -0.94 |
| 7 Days Ago | 0 | 0 | -0.87 | 0.23 |
| 30 Days Ago | 0 | 0 | -0.87 | 0.23 |
| 60 Days Ago | 0 | 0 | -0.87 | 0.23 |
| 90 Days Ago | 0 | 0 | -0.87 | 0.23 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| FBIO | -- | 34.21% | 42.79% | 42.68% |
| S&P 500 | 13.17% | 2.85% | 7.92% | 13.78% |
Upgrades & Downgrades
| Reiterates | Roth MKM: Buy to Buy | 3/11/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/18/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 7/19/2024 |
| Reiterates | Cantor Fitzgerald: Overweight | 6/20/2024 |
| Reiterates | Roth MKM: Buy to Buy | 5/16/2024 |
| Initiated | Alliance Global Partners: Buy | 3/19/2024 |
Related Tickers
CKPT Checkpoint Therapeutics, Inc.
4.1550
+0.12%
MBIO Mustang Bio, Inc.
1.1099
-1.78%
ATXI Avenue Therapeutics, Inc.
0.2101
-12.46%
MIST Milestone Pharmaceuticals Inc.
1.1865
+3.16%
UNCY Unicycive Therapeutics, Inc.
0.5899
+7.15%
CHRS Coherus BioSciences, Inc.
0.8114
+5.65%
ABEO Abeona Therapeutics Inc.
5.73
-1.12%
ALXO ALX Oncology Holdings Inc.
0.4389
+0.71%
SPRO Spero Therapeutics, Inc.
0.6750
+3.65%
OTLK Outlook Therapeutics, Inc.
1.7400
+3.88%